Pollack R J, Telford S R, Spielman A
Department of Tropical Public Health, Harvard School of Public Health, Boston, Massachusetts 02115.
J Clin Microbiol. 1993 May;31(5):1251-5. doi: 10.1128/jcm.31.5.1251-1255.1993.
To standardize the procedure for isolating and culturing Lyme disease spirochetes, we modified the composition of the medium generally used for this purpose (BSK-II) and developed a system for its distribution. This medium contains no gelatin or agarose, and various components are used in proportions that differ from those in BSK-II. Each of the major proteinacious components was screened by substitution in samples of the complete product. The final medium was evaluated for the capacity to grow related spirochetes including Borrelia burgdorferi N40, Guilford, and JD-1 as well as strains of Borrelia hermsii (HS-1) and of Borrelia coriaceae (CO53). Each isolate developed from inocula containing as few as one to five organisms. Doubling time of B. burgdorferi during log-phase growth at 37 degrees C was 10 to 12 h. Lyme disease spirochetes were isolated in this medium from ear punch biopsies and dermal aspirates from naturally infected mice and rabbits, from dermal biopsies from a human patient, and by sampling field-collected deer ticks (Ixodes dammini). Cultured spirochetes remained infective to mice and to ticks. The medium can be stored at -20 degrees C or lower temperatures for at least 8 months without effect on its ability to support growth of small inocula to densities exceeding 10(8) spirochetes per ml. Lyme disease spirochetes remained infective to mice after being stored at -80 degrees C in this medium for at least 8 months. We anticipate that the availability of this standardized medium (Sigma Chemical Co.), supplemented with prescreened rabbit serum, will facilitate comparison of research results between laboratories and may eventually permit definitive clinical diagnosis of Lyme disease based on demonstration of the pathogen. The standardized medium is designated BSK-H.
为规范莱姆病螺旋体的分离培养程序,我们对通常用于此目的的培养基(BSK-II)的成分进行了改良,并开发了一种培养基分发系统。这种培养基不含明胶或琼脂糖,其各种成分的使用比例与BSK-II不同。通过在完整产品样本中进行替换,对每种主要蛋白质成分进行了筛选。对最终培养基培养相关螺旋体的能力进行了评估,这些螺旋体包括伯氏疏螺旋体N40、吉尔福德菌株和JD-1菌株,以及赫氏疏螺旋体(HS-1)菌株和科氏疏螺旋体(CO53)菌株。每个分离株均由接种量低至1至5个生物体的接种物培养而来。伯氏疏螺旋体在37℃对数期生长时的倍增时间为10至12小时。在这种培养基中,从自然感染小鼠和兔子的耳打孔活检组织及皮肤吸出物、一名人类患者的皮肤活检组织以及通过采集野外捕获的鹿蜱(达敏硬蜱)样本中分离出了莱姆病螺旋体。培养的螺旋体对小鼠和蜱仍具有感染性。该培养基可在-20℃或更低温度下储存至少8个月,而不会影响其支持少量接种物生长至每毫升超过10(8)个螺旋体密度的能力。在这种培养基中于-80℃储存至少8个月后,莱姆病螺旋体对小鼠仍具有感染性。我们预计,这种标准化培养基(Sigma化学公司)加上预先筛选的兔血清的可用性,将有助于实验室之间研究结果的比较,并最终可能基于病原体的检测实现莱姆病的明确临床诊断。这种标准化培养基被命名为BSK-H。